Media News

With the efficacy comparable to rival drugs, Oscotec plans to advance to the next step, leaving the door open for partnership PANGYO, South Korea, Feb. 24, 2023 /PRNewswire/ -- Oscotec Inc. announced topline results for Phase 2 trial evaluating the efficacy, safety and tolerability of cevidoplenib (SYK inhibitor) in immune thrombocytopenia (ITP) patients who have failed...

Tibsovo® (ivosidenib tablets) is the first IDH1 inhibitor recommended for approval in Europe The positive CHMP opinion is based on clinical data from the AGILE (in AML) and ClarIDHy (in CCA) studies PARIS, Feb. 24, 2023 /PRNewswire/ -- Servier, a global pharmaceutical company, today announced that the Committee for Medicinal...

SUZHOU, China, Feb. 24, 2023 /PRNewswire/ -- On February 20, 2023, Porton Advanced Solutions Ltd. (Porton Advanced) and Yinjia (Shanghai) Biosciences Co., Ltd. (Yinjia Biosciences) announced a strategic partnership in developing core protein raw materials for cell and gene therapy (CGT) and test reagent products for quality control and evaluation systems to accelerate the development and commercialization of CGT....

INNSBRUCK, Austria, Feb. 24, 2023 /PRNewswire/ -- Today, MED-EL, a leader in implantable hearing solutions, celebrates together with everyone living with and benefiting from cochlear implants. World Cochlear Implant Day pays tribute to the tremendous technological developments since the modern cochlear implant was first invented 45 years ago. To MED-EL, it is...

SHANGHAI, Feb. 24, 2023 /PRNewswire/ -- ChemPartner announced today the appointment of Lilly Xu, Ph.D. as President of Shanghai ChemPartner. Dr. Xu is a seasoned manager with a strong portfolio of success. She joined ChemPartner in 2017 to lead the strategic drug discovery services as Senior Vice President and Head of DMPK...

JIUQUAN, China, Feb. 24, 2023 /PRNewswire/ -- Qilian International Holding Group Ltd (NASDAQ: QLI) ("Qilian" or the "Company"), a China-based pharmaceutical and chemical products manufacturer, today announced it has received a notice of non-compliance from Nasdaq Stock Market LLC ("Nasdaq") on February 16, 2023 stating that, as a result of not having timely filed its annual report on Form...

ST-01 is a MSLA 2.0-powered 3D printer for high throughput digital production in medium to large dental and orthodontic laboratories. ST-32 is a semi-automated 3D printer designed for lights-out manufacturing of clear aligner models New generation of 3D printers are powered by MSLA 2.0, a step improvement of Structo's proprietary MSLA technology in longevity and reliability, delivering better...

Activation Advances Nonclinical Strategies for People with Parkinson's to Deepen Intimacy NEW YORK, Feb. 23, 2023 /PRNewswire/ -- Parkinson's disease affects more than ten million people worldwide and the prevalence of sexual dysfunction is disproportionately high in patients, causing partners to grow apart physically and emotionally. Symptoms like tremor, rigidity, and fatigue can...

NEW YORK, Feb. 23, 2023 /PRNewswire/ -- The TB Alliance Board of Directors has elected David Norton as Chairperson of the Board. In this role, David will provide leadership to a diverse Board committed to advancing the vision of TB Alliance. "David Norton has contributed greatly to TB Alliance's mission over his years of service as a Director," said...

SAN DIEGO, Feb. 23, 2023 /PRNewswire/ -- Today, Invivoscribe announced that its Shanghai lab in China has received CAP accreditation. The College of American Pathologists (CAP) is a professional organization that accredits clinical laboratories across the world. The CAP accreditation process is designed to ensure that laboratories meet or exceed the...